Journal SAM: Risk Assessment and Predictive Value of Coronary Artery Disease Testing
Release Date: 7/1/2012
Expiration Date: 7/1/2016
Members: $45
Non-Members: $90
Continuing Education Credit Information
ABNM SAM Credit
The
American Board of Nuclear Medicine has reviewed and approved this
Journal SAM activity submitted by the SNMMI. This activity fulfills the
requirements of the ABNM Maintenance of Certification program for
self-assessment. 1.5 SAMs have been awarded for this activity.
AMA-PRA (Physician)
The
Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is
accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
SNMMI designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM.
Objectives
Upon completion of this module, participants will be able to:
1. Describe the concordance and discordance of myocardial ischemia and anatomic coronary artery disease.
2. Comprehend the expected cardiac event rates on the basis of the extent and severity of myocardial perfusion abnormalities.
3.
Report the expected 1-year event rates on the basis of the extent and
severity of anatomic coronary artery disease visualized by coronary CT
angiography.
4.
Restate the clinical value of serial testing for evaluation of the
ischemic burden in patients with stable ischemic heart disease.
Target Audience
The
LLSAP is designed for all nuclear medicine specialists and other
physicians, pharmacists and technologists who practice diagnostic
and/or therapeutic nuclear medicine.
In accordance with ACCME Revised Standards for Commercial Support and SNM Conflict-of-Interest Policy, the author has indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.
